DaVita-Brasnefro deal in Brazil should be blocked, CADE unit says
The Brazilian competition authority's investigatory unit has recommended blocking DaVita’s acquisition of Brasnefro. The Superintendence cited high market concentration, barriers to entry and low competition in dialysis services for chronic patients...To view the full article, register now.
Already a subscriber? Click here to view full article